Page 59 - Pharma

Manufacturing trends of 2015: Harsh Marwah

With 2014 coming to an end and Indian manufacturers begin to plan for the year to come, here are five manufacturing trends that will impact the industry in 2015

Strides Arcolab's arm to set up $60-mn biopharma facility in Malaysia

The facility will incorporate 'next-gen' single-use bio-processing technology with both mammalian and microbial manufacturing suites

Wintac hives off oncology products division

Post-separation, Wintac to completely focus on the core activity of product development and manufacturing activity for the regulated export markets

Dr Reddy's API plant receives USFDA's observations

Observations were made by USFDA, after its team visited the plant located at Srikakulam recently

BioMarin to buy Prosensa Holding for $680 mn

In addition, two approximately $80 million contingent milestones are payable for the approval of drisapersen, a potential drug candidate for Duchenne muscular dystrophy

Otsuka Pharma to buy USA's Avanir for $3.5 bn

Avanir company will partner with Otsuka in the US to further enhance its development and commercialisation efforts in CNS-related disorders

AstraZeneca and Eli Lilly start critical clinical trial for Alzheimer's drugs

Companies have initiated a phase II/III study of an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease

Merck commissions biomass energy plant in Goa

The co-generation unit, which has a power output of 3 megawatts, generates electricity and steam for the pharmaceutical and chemical production operations in Goa

Eye-Q launches robotic assisted technology for cataract treatment

The company's Catalys precision laser system will help surgeons deliver predictability and quality of outcomes in cataract surgery

Thermo Fisher joins hand with Samsung for diagnostic solutions

Two companies will jointly design, develop and market new point-of-care solutions in key applications

Aurobindo Pharma recalls anti-epileptic drug in US

The company has issued voluntary nationwide recall of Northstar label gabapentin capsules due to complaints of empty capsules

Lonza to manufacture Sunshine Biopharma's anti-cancer compound

Adva-27a is Sunshine Biopharma's lead anticancer compound, a Topoisomerase II inhibitor, small molecule that has recently been shown to be effective against many cancers

Dr Reddy's launches docetaxel injection in US

The Taxotere (docetaxel injection) brand and generic has US sales of approximately $ 218 million MAT for the most recent twelve months ending in September 2014

Abbvie acquires API facility in Singapore

The facility will expand the company's global operations for small molecule and biologics manufacturing

PerkinElmer to buy Swedish firm Perten Instruments for $266 mn

The acquisition is expected to significantly expand PerkinElmer's presence in the rapidly growing area of food testing

Marine Ingredients buys BASF's omega-3 plant in Norway

The US-based company has acquired BASF's manufacturing facility for natural fish oils, medium-concentrated omega-3s, and customised bottled fish oil in Brattvag, Norway

US court rejects Ranbaxy plea against US FDA

Ranbaxy had filed a lawsuit against US FDA for revoking tentative approvals granted to it for making generics of Valcyte and Nexium

Dr Reddy's launches OTC fexofenadine tabs in US

The company's fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release tablets 60 mg / 120 mg is available in a 20 count blister

Tatarstan eyes collaboration with India in pharma, chemicals, fertilisers

India and Tatarstan to set up a joint working group (JWG) comprising representatives of all three streams - fertilisers, chemicals and petrochemicals, pharmaceuticals

Cipla forms alliance with Serum Institute to market paediatric vaccines in Europe

While Serum Institute will manufacture paediatric vaccines, Cipla will seek approvals and market the products in Europe